Malignant Urinary System Neoplasm — Trials

Malignant Urinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 888
Recruiting: 467
Ph III recruiting: 52
Growth YoY: +13.3%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (556)

clinicaltrialsPublishedShowing 251–300 of 478 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04537221	Nordic Cystectomy Study III - Transfusion(NorCys-Transf)	unknown	—	1,700	Turku University HospitalOTHER_GOV	1	Nov 25, 2020	clinicaltrials
NCT04644432	Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma(INDIGO)	unknown	Phase 2	30	Herlev and Gentofte HospitalOTHER	1	Nov 25, 2020